| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/HEP.510300511 |
| P698 | PubMed publication ID | 10534356 |
| P50 | author | Chang Mei-hwei | Q47688572 |
| Hong-Yuan Hsu | Q40519778 | ||
| P2093 | author name string | Chen HL | |
| Ni YH | |||
| Liaw SH | |||
| P2860 | cites work | Vaccine-induced escape mutant of hepatitis B virus | Q45860147 |
| Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains | Q45866272 | ||
| Detection of Hepatitis B Surface Gene Mutation in Carrier Children with or without Immunoprophylaxis at Birth | Q56787331 | ||
| Qualitative analysis of the humoral immune response to the "a" determinant of HBs antigen after inoculation with plasma-derived or recombinant vaccine | Q68985903 | ||
| Mutational analysis of HBsAg assembly | Q71151008 | ||
| Breakthrough infections and identification of a viral variant in Gambian children immunized with hepatitis B vaccine | Q72468630 | ||
| Prediction of protein antigenic determinants from amino acid sequences | Q29547548 | ||
| Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan | Q34054719 | ||
| Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene | Q34062769 | ||
| Chemically synthesized peptides of hepatitis B surface antigen duplicate the d/y specificities and induce subtype-specific antibodies in chimpanzees | Q37609547 | ||
| Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen | Q39308981 | ||
| Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein. | Q40046380 | ||
| Tbe complete nudeotide sequences of the cloned hepatitis B vims DNA; subtype adr and adw | Q40490677 | ||
| Hepatitis B surface antigen variation and protective immunity | Q41006706 | ||
| Molecular epidemiology of hepatitis B virus vaccine variants in Singapore | Q41008123 | ||
| The clinical significance of surface antigen variants of hepatitis B virus | Q41428169 | ||
| A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers | Q42218019 | ||
| Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine | Q43568480 | ||
| A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B. | Q43661165 | ||
| Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program | Q44674236 | ||
| The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia | Q45759074 | ||
| Altered antigenicity of 'a' determinant variants of hepatitis B virus | Q45759805 | ||
| Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis | Q45760412 | ||
| Increasing heterogeneity of the 'a' determinant of HBsAg found in the presumed late phase of chronic hepatitis B virus infection | Q45763604 | ||
| Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan | Q45768644 | ||
| A novel hepatitis B virus variant in the sera of immunized children | Q45779553 | ||
| Molecular characterization of envelope antigenic variants of hepatitis B virus from Spain | Q45782338 | ||
| Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. | Q45839420 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis B | Q6853 |
| P304 | page(s) | 1312-1317 | |
| P577 | publication date | 1999-11-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan | |
| P478 | volume | 30 |
| Q45740493 | 48-mer synthetic peptide analogue of the hepatitis B virus "a" determinant induces an anti-HBs antibody response after a single injection |
| Q38632945 | A review of strategies to prevent mother-to-infant transmission of hepatitis B virus infection. |
| Q56669408 | A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action |
| Q42665595 | Acute self-limiting hepatitis B after immunoprophylaxis failure in an infant |
| Q36769147 | Administration of hepatitis B vaccine in winter as a significant predictor of the poor effectiveness of vaccination in rural Mongolia: evidence from a nationwide survey |
| Q41962527 | An analysis of the molecular evolution of hepatitis B viral genotypes A/B/D using a Bayesian evolutionary method |
| Q40703644 | Anti-HBs after hepatitis B immunization with plasma-derived and recombinant DNA-derived vaccines: binding to mutant HBsAg |
| Q37254383 | Change in hepatitis B virus large surface antigen variant prevalence 13 years after implementation of a universal vaccination program in China. |
| Q44461497 | Characterization of hepatitis B virus surface antigen and polymerase mutations in liver transplant recipients pre- and post-transplant |
| Q57241733 | Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers |
| Q33801311 | Clinical implications of hepatitis B virus mutations: recent advances |
| Q26773676 | Clinical significance of hepatitis B surface antigen mutants |
| Q33651263 | Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination |
| Q28076279 | Current progress in the development of therapeutic vaccines for chronic hepatitis B virus infection |
| Q40622948 | Deficiency in virion secretion and decreased stability of the hepatitis B virus immune escape mutant G145R |
| Q34496865 | Detecting hepatitis B surface antigen mutants |
| Q47111754 | Detection of HBsAg mutants in the blood donor population of Pakistan |
| Q37124701 | Development of a highly sensitive bioluminescent enzyme immunoassay for hepatitis B virus surface antigen capable of detecting divergent mutants |
| Q34432019 | Does Hepatitis B Virus Prenatal Transmission Result in Postnatal Immunoprophylaxis Failure? |
| Q45412097 | Dynamics of a hepatitis B virus e antigen minus population ascribed to genotype F during the course of a chronic infection despite the presence of anti-HBs antibodies |
| Q57930358 | Editorial |
| Q33903914 | Effect of hepatitis B virus mutants on efficacy of vaccination |
| Q40427997 | Effects of hepatitis B vaccine boosters on anti-HBs-negative children after primary immunization |
| Q43585737 | Efficacy and safety of prophylaxis with entecavir and hepatitis B immunoglobulin in preventing hepatitis B recurrence after living-donor liver transplantation |
| Q57205446 | Eight-year nationwide survival analysis in relatives of patients with hepatocellular carcinoma: Role of viral infection |
| Q37261506 | Evidences of parasite evolution after vaccination |
| Q35765290 | Familial hepatocellular carcinoma in an endemic area: two case reports |
| Q57299782 | Familial hepatocellular carcinoma: 'A model for studying preventive and therapeutic measures' |
| Q38782188 | Functional analysis of 'a' determinant mutations associated with occult HBV in HIV-positive South Africans. |
| Q59360553 | Genetic variation of hepatitis B surface antigen among acute and chronic hepatitis B virus infections in The Netherlands |
| Q34749752 | Global control of hepatitis B virus infection. |
| Q33574740 | Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization? |
| Q37409858 | HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients |
| Q44198141 | HBV infection in indigenous children, 20 years after immunization in Taiwan: a community-based study |
| Q51964512 | HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination. |
| Q44066657 | HLA-DPB1 and anti-HBs titer kinetics in hepatitis B booster recipients who completed primary hepatitis B vaccination during infancy |
| Q36073500 | Hepatitis B Virus Infection in Indonesia 15 Years After Adoption of a Universal Infant Vaccination Program: Possible Impacts of Low Birth Dose Coverage and a Vaccine-Escape Mutant |
| Q81405829 | Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination |
| Q37936822 | Hepatitis B virus S gene escape mutants |
| Q39729787 | Hepatitis B virus infection in adolescents in a rural township--15 years subsequent to mass hepatitis B vaccination in Taiwan |
| Q36028735 | Hepatitis B virus infection in post-vaccination South Africa: occult HBV infection and circulating surface gene variants |
| Q36605805 | Hepatitis B virus mutation in children. |
| Q35782725 | High Prevalence of Hepatitis B Virus Infection in Young Adults in Ternate, Eastern Indonesia. |
| Q27001669 | How grim is hepatocellular carcinoma? |
| Q36046803 | Impact of Universal Hepatitis B Vaccination on Prevalence, Infection-Associated Morbidity and Mortality, and Circulation of Immune Escape Variants in Russia |
| Q43508386 | Impact of universal vaccination on intrafamilial transmission of hepatitis B virus |
| Q34416463 | Impairment of Hepatitis B Virus Virion Secretion by Single-Amino-Acid Substitutions in the Small Envelope Protein and Rescue by a Novel Glycosylation Site |
| Q33998208 | Infection with hepatitis B virus carrying novel pre-S/S gene mutations in female siblings vaccinated at birth: two case reports |
| Q36237755 | Investigation of a Novel Hepatitis B Virus Surface Antigen (HBsAg) Escape Mutant Affecting Immunogenicity. |
| Q43640771 | Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant |
| Q40545036 | Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran. |
| Q58808840 | Molecular Variants of Hepatitis B Surface Antigen (HBsAg) |
| Q35744379 | Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana |
| Q33623694 | Molecular epidemiology and genotyping of hepatitis B virus of HBsAg-positive patients in Oman |
| Q33780105 | Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions |
| Q81360049 | Multicenter study of a new fully automated HBsAg screening assay with enhanced sensitivity for the detection of HBV mutants |
| Q44914689 | Naturally occurring hepatitis B surface gene variants in chronic hepatitis B virus infection: correlation with viral serotypes and clinical stages of liver disease |
| Q40992209 | Occult hepatitis B virus infection and S gene escape mutants in HIV-infected patients after hepatitis B virus vaccination. |
| Q52928127 | Pathogenesis of hepatitis B virus infection. |
| Q78590627 | Presence of hepatitis B surface antigen mutant G145R DNA in the peripheral blood leukocytes of the family members of an asymptomatic carrier and evidence of its horizontal transmission |
| Q47218031 | Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries |
| Q45402181 | Prevention of hepatitis B virus infection by vaccination: Progress and problems |
| Q36298758 | Prevention of liver tumor formation in woodchucks with established hepatocellular carcinoma by treatment with cationic liposome-DNA complexes |
| Q34737132 | Progress in the prevention and control of viral hepatitis type B: closing remarks |
| Q36756215 | Quasispecies and its impact on viral hepatitis |
| Q52599337 | Quasispecies characters of hepatitis B virus in immunoprophylaxis failure infants. |
| Q37285249 | Quasispecies structure, cornerstone of hepatitis B virus infection: mass sequencing approach |
| Q37450812 | Randomized controlled study investigating viral suppression and serological response following pre-S1/pre-S2/S vaccine therapy combined with lamivudine treatment in HBeAg-positive patients with chronic hepatitis B. |
| Q36050544 | Recent developments in the diagnosis and monitoring of HBV infection and role of the genetic variability of the S gene |
| Q42340899 | Reduced prevalence of HBsAg variants following a successful immunization program in China |
| Q79098068 | Selection of a secretion-incompetent mutant in the serum of a patient with severe hepatitis B |
| Q33962523 | Sensitive detection of HBsAg mutants by a gap ligase chain reaction assay |
| Q34719828 | Sensitivities of four new commercial hepatitis B virus surface antigen (HBsAg) assays in detection of HBsAg mutant forms |
| Q80814642 | Short-term response to a booster dose of hepatitis B vaccine in anti-HBs negative adolescents who had received primary vaccination 16 years ago |
| Q34416294 | Structural and functional heterogeneity of naturally occurring hepatitis B virus variants. |
| Q45404079 | Successful interferon treatment in a patient chronically infected with hepatitis B virus carrying unusual S- (and P-) mutants in the presence of anti-HBs antibodies |
| Q41933761 | Surface protein mutations in chronic hepatitis B patients who received hepatitis B vaccine therapy |
| Q35596881 | Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan. |
| Q38656432 | Temporal trend of hepatitis B surface mutations in the post-immunization period: 9 years of surveillance (2005-2013) in eastern China |
| Q37521932 | The effects of booster vaccination on combined hepatitis A and hepatitis B vaccine in both anti-HBs and anti-HAV negative children 5-15 years after hepatitis B vaccine primary immunization |
| Q37514774 | The effects of booster vaccination on hepatitis B vaccine in anti-HBs negative infants of HBsAg-positive mothers after primary vaccination |
| Q34290738 | The effects of different dosage levels of hepatitis B vaccine as booster on anti-HBs-negative children 5-15 y after primary immunization; China, 2009-2010. |
| Q36671958 | The evolutionary epidemiology of vaccination |
| Q34942505 | The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus |
| Q45731783 | Trend of hepatitis B virus infection in freshmen classes at two high schools in Hualien, Taiwan from 1991 to 1999. |
| Q34719636 | Unusual naturally occurring humoral and cellular mutated epitopes of hepatitis B virus in a chronically infected argentine patient with anti-HBs antibodies |
| Q36606836 | Vaccination and the dynamics of immune evasion |
| Q24245861 | Vaccines for preventing hepatitis B in health-care workers |
| Q40143078 | Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme |
| Q60301818 | Why the evolution of vaccine resistance is less of a concern than the evolution of drug resistance |
Search more.